ZDHHC23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.565600E-01
Normal-vs-Stage2
2.610800E-01
Normal-vs-Stage3
9.755500E-03
Normal-vs-Stage4
7.122400E-01
Stage1-vs-Stage2
1.360380E-01
Stage1-vs-Stage3
1.541620E-02
Stage1-vs-Stage4
7.009200E-01
Stage2-vs-Stage3
8.916000E-02
Stage2-vs-Stage4
4.742000E-01
Stage3-vs-Stage4
9.137800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.377200E-01
Normal-vs-AfricanAmerican
6.032000E-01
Normal-vs-Asian
2.683200E-01
Caucasian-vs-AfricanAmerican
4.838200E-01
Caucasian-vs-Asian
9.804400E-01
AfricanAmerican-vs-Asian
5.887800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.124800E-01
Normal-vs-Female
1.553000E-01
Male-vs-Female
1.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.511200E-01
Normal-vs-Age(41-60Yrs)
3.541000E-01
Normal-vs-Age(61-80Yrs)
1.956040E-01
Normal-vs-Age(81-100Yrs)
1.853220E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.620600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.905600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.236600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.186000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.780400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.959600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.546400E-01
Normal-vs-Daily Drinker
4.915000E-01
Normal-vs-Weekly Drinker
4.396400E-01
Normal-vs-Occasional Drinker
3.263800E-01
Normal-vs-Social Drinker
2.925600E-01
Non Drinker-vs-Daily Drinker
5.262000E-01
Non Drinker-vs-Weekly Drinker
6.148000E-01
Non Drinker-vs-Occasional Drinker
3.213600E-01
Non Drinker-vs-Social Drinker
4.514200E-01
Daily Drinker-vs-Weekly Drinker
9.231800E-01
Daily Drinker-vs-Occasional Drinker
8.890400E-01
Daily Drinker-vs-Social Drinker
9.974200E-01
Weekly Drinker-vs-Occasional Drinker
8.044800E-01
Weekly Drinker-vs-Social Drinker
9.153800E-01
Occasional Drinker-vs-Social Drinker
8.649000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.023200E-03
Normal-vs-Grade 2
1.611910E-02
Normal-vs-Grade 3
6.657700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.357800E-01
Grade 1-vs-Grade 3
2.173600E-01
Grade 1-vs-Grade 4
6.023200E-03
Grade 2-vs-Grade 3
7.741200E-01
Grade 2-vs-Grade 4
1.611910E-02
Grade 3-vs-Grade 4
6.657700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.751220E-01
Normal-vs-NonDiabetic
2.487200E-01
Diabetic-vs-NonDiabetic
4.395600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.355800E-01
Normal-vs-NoPancreatitis
1.888160E-01
Pancreatitis-vs-NoPancreatitis
3.649900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.493400E-01
Normal-vs-N1
2.305400E-01
N0-vs-N1
7.147600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.607200E-01
Normal-vs-TP53-NonMutant
7.280400E-01
TP53-Mutant-vs-TP53-NonMutant
7.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
